Clinical Trial Update: Safety and Immunogenicity of an Inactivated EV71 Vaccine in Infants [Phase 2]

View source ↗

Summary

Phase 2 trial in infants evaluates safety and immunogenicity of an inactivated Enterovirus 71 vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enterovirus Infection
• Hand Foot and Mouth Disease

Drugs mentioned

• Inactivated Enterovirus 71 vaccine (Inactivated Enterovirus 71 vaccine)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Infection, Viral, Enterovirus | Phase 2 | Status: COMPLETED